Evolution of anti-influenza vaccination coverage in Spain from 1993 to 2001

被引:19
|
作者
Jiménez-García, R
Mayo-Montero, E
Hernández-Barrera, V
Sierra-Moros, MJ
del Amo, IP
Carrasco-Garridoa, P
Martinez-Hernandez, D
de Miguel, AG
机构
[1] Univ Rey Juan Carlos, Fac Ciencias Salud, Unidad Docencia & Invest Med Prevent & Salud Publ, Alcorcon 28922, Spain
[2] Minist Sanidad & Consumo, Direcc Gen Salud Publ, Subdirecc Gen Promoc Salud & Epidemiol, E-28014 Madrid, Spain
[3] Univ Complutense Madrid, Fac Med, Dept Med Prevent & Salud Publ, E-28040 Madrid, Spain
关键词
influenza; vaccines; epidemiology;
D O I
10.1016/j.vaccine.2004.11.055
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objective of this study is to describe the evolution of anti-influenza vaccination coverage in Spain from 1993 to 2001. We analysed 55,040 questionnaires taken from the Spanish National Health Surveys from the years 1993, 1995, 1997 and 2001. The reply to the question "Did you vaccinate yourself against influenza during the last campaign?" is the dependent variable. Independent variables were the year of the survey, age, sex and the coexistence of chronic conditions. After adjusting using logistic regression, we found a significant improvement during the study period among those subjects at risk of suffering complications from influenza (OR 1.21). Nevertheless, this increase was essentially at the cost of subjects aged 65 and over. Subjects with high-risk conditions under 65 did not undergo significant changes. Conclusions: A significant but insufficient improvement has been achieved and this must lead us to consider the possible need to modify anti-influenza vaccination recommendations. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2844 / 2850
页数:7
相关论文
共 50 条
  • [1] Evolution of influenza vaccination coverage in France from 2001 to 2006
    Lina, B.
    Holm, M. V.
    Szucs, T. D.
    MEDECINE ET MALADIES INFECTIEUSES, 2008, 38 (03): : 125 - 132
  • [2] Influenza vaccination among diabetic adults -: Related factors and trend from 1993 to 2001 in Spain
    Jiménez-García, R
    Mayo-Montero, E
    Hernández-Barrera, V
    Garrido, PC
    Martinez-Hernandez, D
    de Miguel, AG
    DIABETES CARE, 2005, 28 (08) : 2031 - 2033
  • [3] ANTI-INFLUENZA VACCINATION - PRESENT AND FUTURE
    HANNOUN, C
    REVUE FRANCAISE DES MALADIES RESPIRATOIRES, 1977, 5 (5-6): : 579 - 584
  • [4] Changes in influenza vaccination coverage in Spain from 2001 to 2003.: Analysis by autonomous communities
    Vazquez-Fernandez del Pozo, Silvia
    Hernandez-Barrera, Valentin
    Carrasco-Garrido, Pilar
    Gil de Miguel, Angel
    Jimenez-Garcia, Rodrigo
    GACETA SANITARIA, 2007, 21 (01) : 10 - 17
  • [5] GLYCOPROTEIN-BIOSYNTHESIS AFTER ANTI-INFLUENZA VACCINATION
    PESCHARD, MJ
    LOUISOT, P
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1975, 6 (04): : 263 - 266
  • [6] ANTI-INFLUENZA VACCINATION DURING STEROID-THERAPY
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1972, 2 (5816): : 763 - +
  • [7] Severe autoimmune thrombopenia following anti-influenza vaccination
    Granier, H
    Nicolas, X
    Laborde, JP
    Talarmin, F
    PRESSE MEDICALE, 2003, 32 (26): : 1223 - 1224
  • [8] EFFECTS OF REPEATED ANTI-INFLUENZA VACCINATION IN A CENTER FOR ELDERLY
    BENTEJAC, MC
    LARBAIGT, G
    NOUVELLE PRESSE MEDICALE, 1978, 7 (34): : 3050 - 3050
  • [9] Takotsubo syndrome in patients with influenza infection or anti-influenza (Flu) vaccination
    Desai, Rupak
    Parekh, Tarang
    Raina, Jilmil
    Itare, Vikram
    Gandhi, Zainab
    Ghadri, Jelena R.
    Templin, Christian
    Paul, Timir K.
    Sachdeva, Rajesh
    Kumar, Gautam
    AGING AND HEALTH RESEARCH, 2021, 1 (03):
  • [10] Why not include an anti-pneumococcal vaccination in the anti-influenza program?
    Diabaté, V
    PRESSE MEDICALE, 2003, 32 (02): : 51 - 52